1. Home
  2. FFC vs CTKB Comparison

FFC vs CTKB Comparison

Compare FFC & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FFC
  • CTKB
  • Stock Information
  • Founded
  • FFC 1983
  • CTKB 1990
  • Country
  • FFC United States
  • CTKB United States
  • Employees
  • FFC N/A
  • CTKB N/A
  • Industry
  • FFC Trusts Except Educational Religious and Charitable
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • FFC Finance
  • CTKB Health Care
  • Exchange
  • FFC Nasdaq
  • CTKB Nasdaq
  • Market Cap
  • FFC 757.4M
  • CTKB 879.8M
  • IPO Year
  • FFC N/A
  • CTKB 2021
  • Fundamental
  • Price
  • FFC $16.06
  • CTKB $5.88
  • Analyst Decision
  • FFC
  • CTKB Strong Buy
  • Analyst Count
  • FFC 0
  • CTKB 2
  • Target Price
  • FFC N/A
  • CTKB $9.25
  • AVG Volume (30 Days)
  • FFC 164.1K
  • CTKB 758.4K
  • Earning Date
  • FFC 01-01-0001
  • CTKB 02-26-2025
  • Dividend Yield
  • FFC 6.79%
  • CTKB N/A
  • EPS Growth
  • FFC N/A
  • CTKB N/A
  • EPS
  • FFC N/A
  • CTKB N/A
  • Revenue
  • FFC N/A
  • CTKB $201,210,000.00
  • Revenue This Year
  • FFC N/A
  • CTKB $8.18
  • Revenue Next Year
  • FFC N/A
  • CTKB $11.15
  • P/E Ratio
  • FFC N/A
  • CTKB N/A
  • Revenue Growth
  • FFC N/A
  • CTKB 9.88
  • 52 Week Low
  • FFC $11.90
  • CTKB $4.66
  • 52 Week High
  • FFC $14.96
  • CTKB $9.33
  • Technical
  • Relative Strength Index (RSI)
  • FFC 62.50
  • CTKB 41.85
  • Support Level
  • FFC $15.55
  • CTKB $5.37
  • Resistance Level
  • FFC $15.88
  • CTKB $7.30
  • Average True Range (ATR)
  • FFC 0.19
  • CTKB 0.40
  • MACD
  • FFC 0.04
  • CTKB -0.14
  • Stochastic Oscillator
  • FFC 97.22
  • CTKB 26.42

About FFC Flaherty & Crumrine Preferred and Income Securities Fund Incorporated

Flaherty & Crumrine Preferred and Income Securities Fund Incorporated is a diversified, closed-end management investment company. The fund's investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. It invests in a diversified portfolio of preferred securities.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: